Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tabassome Simon

Showing results (261-270 of 272) with videos related to

Pageof 28
Sort By:
Nature|August 26, 2021
APRIL limits atherosclerosis by binding to heparan sulfate proteoglycansDimitrios Tsiantoulas, Mahya Eslami, Georg Obermayer, et al.
Iscience|August 31, 2021
A randomized trial of icosapent ethyl in ambulatory patients with COVID-19Andrew Kosmopoulos, Deepak L Bhatt, Gus Meglis, et al.
The New England Journal of Medicine|June 7, 2018
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary CholangitisChristophe Corpechot, Olivier Chazouillères, Alexandra Rousseau, et al.
Heart Failure Reviews|February 12, 2025
Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysisBeth A Davison, Antonio Abbate, Gad Cotter, et al.
The Lancet. Respiratory Medicine|September 10, 2021
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trialJean-Marc Naccache, Stéphane Jouneau, Morgane Didier, et al.
The New England Journal of Medicine|August 26, 2022
Polypill Strategy in Secondary Cardiovascular PreventionJose M Castellano, Stuart J Pocock, Deepak L Bhatt, et al.
American Heart Journal|April 15, 2018
Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)Thomas O Bergmeijer, Jean-Luc Reny, Ruth E Pakyz, et al.
The New England Journal of Medicine|November 12, 2023
Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and AnemiaJeffrey L Carson, Maria Mori Brooks, Paul C Hébert, et al.
Eclinicalmedicine|March 30, 2022
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study groupOlivier Hermine, Xavier Mariette, Raphael Porcher, et al.
Circulation|July 14, 2020
Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant DataBakhtawar K Mahmoodi, Vinicius Tragante, Marcus E Kleber, et al.
Pageof 28

Showing results (261-270 of 272) with videos related to

Sort By:
Pageof 28
Nature|August 26, 2021
APRIL limits atherosclerosis by binding to heparan sulfate proteoglycansDimitrios Tsiantoulas, Mahya Eslami, Georg Obermayer, et al.
Iscience|August 31, 2021
A randomized trial of icosapent ethyl in ambulatory patients with COVID-19Andrew Kosmopoulos, Deepak L Bhatt, Gus Meglis, et al.
The New England Journal of Medicine|June 7, 2018
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary CholangitisChristophe Corpechot, Olivier Chazouillères, Alexandra Rousseau, et al.
Heart Failure Reviews|February 12, 2025
Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysisBeth A Davison, Antonio Abbate, Gad Cotter, et al.
The Lancet. Respiratory Medicine|September 10, 2021
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trialJean-Marc Naccache, Stéphane Jouneau, Morgane Didier, et al.
The New England Journal of Medicine|August 26, 2022
Polypill Strategy in Secondary Cardiovascular PreventionJose M Castellano, Stuart J Pocock, Deepak L Bhatt, et al.
American Heart Journal|April 15, 2018
Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)Thomas O Bergmeijer, Jean-Luc Reny, Ruth E Pakyz, et al.
The New England Journal of Medicine|November 12, 2023
Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and AnemiaJeffrey L Carson, Maria Mori Brooks, Paul C Hébert, et al.
Eclinicalmedicine|March 30, 2022
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study groupOlivier Hermine, Xavier Mariette, Raphael Porcher, et al.
Circulation|July 14, 2020
Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant DataBakhtawar K Mahmoodi, Vinicius Tragante, Marcus E Kleber, et al.
Pageof 28